A detailed history of Allspring Global Investments Holdings, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 7,820 shares of ARCT stock, worth $186,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,820
Previous 29,557 73.54%
Holding current value
$186,741
Previous $998,000 80.96%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$24.35 - $44.39 $529,295 - $964,905
-21,737 Reduced 73.54%
7,820 $190,000
Q1 2024

Apr 18, 2024

SELL
$31.23 - $42.99 $2.66 Million - $3.67 Million
-85,253 Reduced 74.26%
29,557 $998,000
Q4 2023

Jan 25, 2024

BUY
$17.71 - $32.97 $1.41 Million - $2.62 Million
79,387 Added 224.11%
114,810 $3.62 Million
Q3 2023

Oct 27, 2023

BUY
$25.44 - $37.35 $901,161 - $1.32 Million
35,423 New
35,423 $905,000
Q2 2023

Jul 18, 2023

BUY
$23.94 - $32.36 $904,836 - $1.22 Million
37,796 Added 789.72%
42,582 $1.22 Million
Q1 2023

Apr 13, 2023

BUY
$14.72 - $23.97 $43,585 - $70,975
2,961 Added 162.25%
4,786 $114,000
Q4 2022

Jan 23, 2023

BUY
$14.14 - $23.06 $9,516 - $15,519
673 Added 58.42%
1,825 $0
Q3 2022

Oct 26, 2022

BUY
$13.05 - $22.13 $15,033 - $25,493
1,152 New
1,152 $17,000
Q2 2022

Jul 25, 2022

SELL
$12.26 - $31.17 $10,273 - $26,120
-838 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$17.64 - $39.57 $829 - $1,859
-47 Reduced 5.31%
838 $22,000
Q4 2021

Jan 28, 2022

BUY
$34.2 - $47.56 $30,267 - $42,090
885 New
885 $32,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $635M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.